Home Machinery & Equipment Automation Lab Automation Market

Lab Automation Market Size, Share & Trends Analysis Report By Product (System, Software), By Applications (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Microbiology, Others), By Automation (Subtotal Automation, Task Targeted Automation, Total Laboratory Automation), By End-User (Biotechnology and Pharma Companies, Hospitals and Diagnostic Laboratories, Forensic Laboratories, Food and Beverages, Environmental Testing Laboratories, Research and Academic Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 28, 2026 | Author: Ismail Sutaria | Format:

Lab Automation Market Size

The global lab automation market size was valued at USD 7.78 billion in 2025 and is projected to grow from USD 8.43 billion in 2026 to USD 16.01 billion by 2034, registering a CAGR of 8.35% during the forecast period from 2026 to 2034. North America dominated the lab automation market with a market share of 39.2% in 2025.

Laboratory automation is a process in which the use of instruments to perform laboratory processes are high with limiting human input. The major reasons for the adoption of laboratory automation are to improve the accuracy of lab results and to improve the workflow efficiently and effectively. Manual processes rely on human workers, with high chances of errors. In addition, automation in the laboratory refers to using technology to enhance existing procedures and enable new, more effective ones. A laboratory automation system comprises several parts, including computer hardware and software, robotics, conveyor systems, and machine vision.

For laboratories to stay competitive in the market today, lab automation is becoming a more viable and necessary solution. The use of contemporary automation technology spares researchers from doing tedious chores. Automation in the lab facilitates patient results delivery by enabling laboratory staff to control the influx of samples and improve throughput. The broader healthcare business is benefiting from the lab automation solution.

Lab Automation Market Size

Download a Free Sample To learn more about this report.

01

Increased Adoption of Automated Workstations

Automated workstations are increasingly used in laboratories to improve performance and productivity. Automated workstations relieve lab personnel from intense concentration demands and fatigue, which can result from various experiments. These automated workstations helped them by freeing them to make more productive utilization of their time. In addition, customized automated lab liquid-handling workstations will keep labs functioning in the absence of the personnel and keep assays moving on weekends so that the research labs can get most of the work completed before the first working day in the week. There is an increased use of customized lab workstations.

Many large laboratories employ automated liquid handlers as stand-alone devices, moving plates manually on and off the stage to storage incubators, and readers are using automated workstations. Most labs are adding new features to liquid-handling benchtop analyzers, enabling automation by shifting to workstations. Adopting total lab automation is expensive, where workstations can increase the efficiency of the labs and reduce manual errors in the process. These factors are expected to boost the market during the forecast period.

02

Increased Product Launches

The vendors strategically focus on developing and commercial launches of lab-automated analyzers, workstations, and automated process-oriented analyzers. Vendors are launching innovative devices to penetrate and exploit the market's enormous growth potential. Moreover, vendors actively engage in R&D activities and plan to launch innovative products in the coming years. For instance, key players such as Danaher, Agilent Technologies, Tecan, and Thermo Fischer Scientific dominate the global market due to their continuous involvement in product innovations and launches. Similarly, the effect of new product approvals and launches has positively impacted the market and is contributing to the expansion of the market.

01

Slow Adoption of Automation among Smls

The adoption of automation technologies has been slow in the market, especially among small and medium-sized laboratories (SMLs). Laboratories investing in automation systems require a larger volume for operation, at least two million tests per year. Only a handful of large laboratories and hospitals implement and benefit from this largely. Many laboratories focus on implementing total laboratory automation, which was a failure in the initial stages. This created a huge resistance to laboratories shifting from manual processes to complete automation. In addition, the cost of automation is very high for SMLs and hospitals, as earning ROI from laboratory automation is a long process. Therefore, such factors hamper the market growth.

01

Robotics Revolutionizing Lab Automation

The general definition of laboratory robotics is the use of robotics technology to conduct scientific studies and research activities in a secure environment without the involvement of human hands. Due to the increasing need to protect the safety of human workers and the installation of tight regulatory standards in laboratories, businesses are beginning to adopt robotic technology for crucial process applications. The popularity of robotics in diagnostic laboratories, research and development centers, and other settings is fueled by robots' ability to maintain accuracy and precision and their high-efficiency level.

Robotic lab automation proved to be beneficial during the covid-19 pandemic. Robotic labs were crucial in diagnosing COVID-19 samples because they offer end-to-end automation. Many laboratory processes are suited for robotic automation –mostly repetitive movements, such as picking and placing heating and cooling specimens and mixing, shaking, and testing specimens. Much progress has been made in the automation and robotization of analytical separation and processing in recent years. This will likely create a huge market opportunity for vendors catering to this market.

Segmental Analysis

By Product

The global market is divided into systems and software. The systems segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 6.16% over the forecast period. Lab automation systems are available in various positions of the product life cycle. Microplate readers are still in the introductory phase, where the adoption of microplate readers is still in the initial stages of the market. Automated robots in the liquid handling segments are growing due to their increased advantages, like reducing manual pipetting errors, being able to perform repetitive work without any errors, especially in the drug discovery process, and research labs performing repetitive tasks, which are difficult for humans. In addition, handling the smaller volume of samples in the market is another feature driving the lab's robotic instruments. The systems segment is sub-segmented into robotic systems, automated workstations, and microplate readers.

Lab Automation Market Size By Segments

Request Customizationto receive a tailored report.

By Application

The global market is bifurcated into drug discovery, clinical diagnostics, genomics solutions, microbiology, and others. The drug discovery segment owns the highest market and is predicted to exhibit a CAGR of 8.50% over the forecast period. Drug discovery labs can reduce the process of designing, synthesizing, and screening a compound from weeks to days. This process is very complex and requires longer. This is the reason behind the limited number of people in the drug discovery process. In addition, many companies are focusing on reducing these risks from the drug development process. One solution for these problems is laboratory automation in the market. Automated robots and workstations help researchers rapidly evaluate many compounds' activity against a specific biological target, which is made possible through high-throughput screening. One of the major advantages is that it enables them to test thousands to hundreds of thousands of agents (small molecules or functional genomics tools) rapidly and reproducibly. In laboratories, procedures are automated using robots, plate readers, and specialized instrumentation control and data processing software.

By Automation

The global market is segmented into task-targeted automation, subtotal automation, and total laboratory automation segments. The subtotal automation segment is the largest contributor to the market and is projected to exhibit a CAGR of 8.51% over the forecast period. The lab process is generally classified into preanalytical, analytical, and post-analytical stages. When one or two stages in this process are automated, it is called subtotal automation. These are usually stand-alone or independent specimen processing systems that are automated for various tasks. The subtotal automation costs are lower than the total laboratory automation implementation. Some medium and a few smaller labs plan to move toward subtotal automation. However, this trend has changed, and more labs are moving completely to total laboratory automation to increase quality and reduce turnaround time. Beckman Coulter has one of the subtotal automation product systems, the AutoMate 800 Sample Processor, designed for laboratories with daily workloads of 500–1500 specimens.

By End-User

The global market is bifurcated into biotech and pharma, hospitals and diagnostic labs, forensics, food and beverage, environmental testing laboratory, and research and academic institutes. The biotech and pharma segment dominates the global market and is predicted to exhibit a CAGR of 8.62% during the forecast period. The biotechnology and pharma companies use automated laboratory instruments largely. May pharma companies use automated lab equipment in quality testing and their research and development platforms. Manufacturing facilities have started to create paperless labs, optimize testing, and automate processes for their quality analysis process. The improved agility with reduced testing time can reduce lead times for quality control labs by 60% to 70%, eventually leading to real-time product releases. Regularly testing the microbial load of raw materials and finished products is an important process in the pharmaceutical and biotechnology industry. Sophisticated analytical methods have been widely applied for quality control analysis in the pharmaceutical sector.

Lab Automation Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Dominant Region

North America is the most significant global lab automation market shareholder and is estimated to exhibit a CAGR of 7.24% over the forecast period. The US adopted the successful lab automation approach after Japan at first. Many hospitals began to automate their labs to deal with the lack of lab staff, enhance the caliber of test decisions, and improve patient care. Traditional device-based diagnostics were more expensive for insurance companies. Therefore, some insurance companies and government organizations cut back on reimbursement throughout the previous ten years. As a result, they began to use new instruments, which is when the market saw the introduction of automation. This circumstance forced hospitals and labs to choose lab automation. In addition, more than 530 regenerative medicine companies and stem cell medicine manufacturers are in the region. These companies are primarily involved in the R&D of products. The laboratories required for these procedures involve advanced infrastructures such as automated analyzers and liquid-handling instruments connected with LIMS to handle and track many samples, thereby fostering the regional market growth.

North America Lab Automation Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Growing Region

Europe is anticipated to exhibit a CAGR of 7.80% ov

List of Key and Emerging Players in Lab Automation Market

Danaher Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Illumia Labs (U.S.)
Abbott Laboratories (U.S.)
LabVantage Solutions, Inc. (U.S.)
Agilent Technologies, Inc. (U.S.)
Aurora Biomed Inc. (Canada)
Accelerated Technologies, Inc. (U.S.)
bioMérieux SA (France)
Bio-Rad Laboratories, Inc. (U.S.)
CrelioHealth (India)
Dassault Systèmes SE (France)
F. Hoffmann-La Roche AG (Switzerland)
INTEGRA Biosciences AG (Switzerland)
LabLynx, Inc. (U.S.)
Peak Analysis & Automation Ltd. (United Kingdom)
Siemens Healthineers AG (Germany)

Report Scope

Segmentation

By Product 2
  • System
  • Software
By Applications 5
  • Drug Discovery
  • Clinical Diagnostics
  • Genomics Solutions
  • Microbiology
  • Others
By Automation 3
  • Subtotal Automation
  • Task Targeted Automation
  • Total Laboratory Automation
By End-User 6
  • Biotechnology and Pharma Companies
  • Hospitals and Diagnostic Laboratories
  • Forensic Laboratories
  • Food and Beverages
  • Environmental Testing Laboratories
  • Research and Academic Institutes

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Danaher Corporation (U.S.) · Thermo Fisher Scientific Inc. (U.S.) · Tecan Group Ltd. (Switzerland) · Illumia Labs (U.S.) · Abbott Laboratories (U.S.)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The global lab automation market size was valued at USD 7.78 billion in 2025 and is projected to reach USD 16.01 billion by 2034, growing at a CAGR of 8.35% during the forecast period from 2026 to 2034.

The market is driven by increasing demand for faster and more accurate laboratory testing, rising pharmaceutical and biotechnology research activities, and the need to reduce manual errors. Growing adoption of automated sample handling, robotic systems, and high-throughput screening technologies further supports market growth.

North America dominates the global lab automation market, supported by advanced healthcare infrastructure, substantial investments in life sciences research, and widespread adoption of automated laboratory technologies. Asia-Pacific is expected to experience significant growth due to expanding healthcare infrastructure and increasing research and development activities.

Key players in the lab automation market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Tecan Group Ltd., QIAGEN N.V., Eppendorf SE, and Hamilton Company. These companies focus on developing automated liquid handling systems, laboratory robotics, sample management solutions, and integrated laboratory platforms.

The lab automation market is segmented by product into systems and software; by application into drug discovery, clinical diagnostics, genomics solutions, microbiology, and others; by automation type into subtotal automation, task-targeted automation, and total laboratory automation; by end user into biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, forensic laboratories, food and beverage companies, environmental testing laboratories, and research and academic institutes. The market is also segmented by region into North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.
About the Author
Ismail Sutaria
Ismail Sutaria
Research Head

Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.

His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: